her2 breast cancer
Posted on 2017-03-29 Tagged in her2, breast, cancer

Targeted OncologyHER2 Guidelines for Breast Cancer Could Misclassify Some PatientsCancer NetworkThe 2013/2014 American Society of Clinical Oncology-College of American Pathologists (ASCO-CAP) guidelines for HER2 gene amplification testing leave some patients at risk for misclassification and inappropriate treatment. These results were presented Patients Liable to Be Misclassified Under New HER2 Gene Testing Guidelines, Expert SaysTargeted OncologyDr. Osborne Discusses the Future of Treatmen

Read More...